Randomized Phase II/III Study of Nivolumab plus Ipilimumab plus Sargramostim versus Nivolumab plus Ipilimumab in Patients with Unresectable Stage III or Stage IV Melanoma

For more information about this clinical trial, click here.

Schema & Eligibility ECOG-ACRIN EA6141

Available at:

Cox Health Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Care Cancer Center, Bolivar, MO
Freeman Health System, Joplin, MO
Mercy Hospital Joplin, MO
Mercy Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO
Mercy Hospital, Washington, MO